BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harsha C, Banik K, Ang HL, Girisa S, Vikkurthi R, Parama D, Rana V, Shabnam B, Khatoon E, Kumar AP, Kunnumakkara AB. Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials. Int J Mol Sci 2020;21:E3285. [PMID: 32384682 DOI: 10.3390/ijms21093285] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Saproo S, Sarkar SS, Gautam V, Konyak CW, Dass G, Karmakar A, Sharma M, Ahuja G, Gupta A, Tayal J, Mehta A, Naidu S. Salivary protein kinase C alpha and novel microRNAs as diagnostic and therapeutic resistance markers for oral squamous cell carcinoma in Indian cohorts. Front Mol Biosci 2022;9:1106963. [PMID: 36703917 DOI: 10.3389/fmolb.2022.1106963] [Reference Citation Analysis]
2 Park DB, Park BS, Kang HM, Kim JH, Kim IR. Chrysophanol-Induced Autophagy Disrupts Apoptosis via the PI3K/Akt/mTOR Pathway in Oral Squamous Cell Carcinoma Cells. Medicina (Kaunas) 2022;59. [PMID: 36676666 DOI: 10.3390/medicina59010042] [Reference Citation Analysis]
3 Sanghavi A, Srivatsa A, Adiga D, Chopra A, Lobo R, Kabekkodu SP, Gadag S, Nayak U, Sivaraman K, Shah A. Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Res 2022;11:1563. [DOI: 10.12688/f1000research.129250.1] [Reference Citation Analysis]
4 Su YC, Lee WC, Wang CC, Yeh SA, Chen WH, Chen PJ. Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas. Int J Mol Sci 2022;23. [PMID: 36555391 DOI: 10.3390/ijms232415749] [Reference Citation Analysis]
5 Amaral MN, Faísca P, Ferreira HA, Gaspar MM, Reis CP. Current Insights and Progress in the Clinical Management of Head and Neck Cancer. Cancers (Basel) 2022;14. [PMID: 36551565 DOI: 10.3390/cancers14246079] [Reference Citation Analysis]
6 Mohamad NA, Rahman AA, Sheikh Abdul Kadir SH. Hydroxychavicol as a potential anticancer agent (Review). Oncol Lett 2023;25:34. [PMID: 36589673 DOI: 10.3892/ol.2022.13620] [Reference Citation Analysis]
7 Govindarasu M, Prathap L, Govindasamy R. Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway. Oral Oncology 2022;135:106221. [DOI: 10.1016/j.oraloncology.2022.106221] [Reference Citation Analysis]
8 Bai L, Wu KL, Chiu C, Chao H, Lin W, Hu J, Peng B, Weng J. Extract of Ficus septica modulates apoptosis and migration in human oral squamous cell carcinoma cells. Environmental Toxicology 2022. [DOI: 10.1002/tox.23716] [Reference Citation Analysis]
9 Yun H, Park JE, Lee JY, Park K. Latifolin, a Natural Flavonoid, Isolated from the Heartwood of Dalbergia odorifera Induces Bioactivities through Apoptosis, Autophagy, and Necroptosis in Human Oral Squamous Cell Carcinoma. IJMS 2022;23:13629. [DOI: 10.3390/ijms232113629] [Reference Citation Analysis]
10 Kavitha M, Jayachandran D, Aishwarya SY, Md. Younus P, Venugopal A, Suresh Babu HW, Ajay E, Sanjana M, Arul N, Balachandar V. A new insight into the diverse facets of microRNA-31 in oral squamous cell carcinoma. Egypt J Med Hum Genet 2022;23:149. [DOI: 10.1186/s43042-022-00361-2] [Reference Citation Analysis]
11 Zhang G, Zhang K, Zhao Y, Yang Q, Lv X. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma. BMC Cancer 2022;22:1103. [DOI: 10.1186/s12885-022-10195-1] [Reference Citation Analysis]
12 Liu J, Wee Y, Luo S, Chang S, Jia S, Feng S, Huang H, Lin J, Wang C. Proanthocyanidins-loaded complex coacervates-based drug delivery attenuates oral squamous cell carcinoma cells metastatic potential through down-regulating the Akt signaling pathway. Front Oncol 2022;12:1001126. [DOI: 10.3389/fonc.2022.1001126] [Reference Citation Analysis]
13 Shi Y, Gao Q, Liu Z, Shen G, Sun X, Di X, Cao S. Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical Cancer. Journal of Oncology 2022;2022:1-20. [DOI: 10.1155/2022/6906380] [Reference Citation Analysis]
14 Yin P, Chen J, Wu Y, Gao F, Wen J, Zhang W, Su Y, Zhang X, Amantini C. Chemoprevention of 4NQO-Induced Mouse Tongue Carcinogenesis by AKT Inhibitor through the MMP-9/RhoC Signaling Pathway and Autophagy. Analytical Cellular Pathology 2022;2022:1-15. [DOI: 10.1155/2022/3770715] [Reference Citation Analysis]
15 Ezhilarasan D, Shree Harini K. Novel mTOR inhibitors: Promising therapeutic interventions in oral cancer therapy. Oral Oncol 2022;133:106066. [PMID: 35961263 DOI: 10.1016/j.oraloncology.2022.106066] [Reference Citation Analysis]
16 Lo YL, Lin HC, Tseng WH. Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer. Acta Biomater 2022:S1742-7061(22)00586-4. [PMID: 36115656 DOI: 10.1016/j.actbio.2022.09.027] [Reference Citation Analysis]
17 Khatoon E, Hegde M, Kumar A, Daimary UD, Sethi G, Bishyaee A, Kunnumakkara AB. The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Arch Pharm Res . [DOI: 10.1007/s12272-022-01398-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Sajeev A, Hegde M, Daimary UD, Kumar A, Girisa S, Sethi G, Kunnumakkara AB. Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Delgado L, Brilhante-simões P, Garcez F, Monteiro L, Pires I, Prada J. p-S6 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma. Biomolecules 2022;12:935. [DOI: 10.3390/biom12070935] [Reference Citation Analysis]
20 Liu W, Wang J, Zhang C, Bao Z, Wu L. Curcumin nanoemulsions inhibit oral squamous cell carcinoma cell proliferation by PI3K/Akt/mTOR suppression and miR-199a upregulation: A preliminary study. Oral Dis 2022. [PMID: 35689522 DOI: 10.1111/odi.14271] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Shiau J, Chuang Y, Cheng Y, Tang J, Hou M, Yen C, Chang H. Impacts of Oxidative Stress and PI3K/AKT/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism. Antioxidants 2022;11:911. [DOI: 10.3390/antiox11050911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
22 Fu H, Zhao D, Sun L, Huang Y, Ma X. Identification of autophagy-related biomarker and analysis of immune infiltrates in oral carcinoma. J Clin Lab Anal 2022;:e24417. [PMID: 35421271 DOI: 10.1002/jcla.24417] [Reference Citation Analysis]
23 Hsu P, Hsu C, Hsia Y, Kuo C. Chrysophanol Suppresses Cell Growth via mTOR/PPAR-α Regulation and ROS Accumulation in Cultured Human Tongue Squamous Carcinoma SAS Cells. CIMB 2022;44:1528-38. [DOI: 10.3390/cimb44040104] [Reference Citation Analysis]
24 Shan J, Wang Z, Mo Q, Long J, Fan Y, Cheng L, Zhang T, Liu X, Wang X. Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway. Pancreatology 2022;22:401-13. [PMID: 35300916 DOI: 10.1016/j.pan.2022.03.002] [Reference Citation Analysis]
25 Parama D, Girisa S, Khatoon E, Kumar A, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. An Overview of the Pharmacological Activities of Scopoletin against Different Chronic Diseases. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
26 Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Front Oncol 2022;12:819128. [DOI: 10.3389/fonc.2022.819128] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
27 Tang J, Cheng Y, Chuang Y, Yang K, Chang F, Liu W, Chang H. Oxidative Stress and AKT-Associated Angiogenesis in a Zebrafish Model and Its Potential Application for Withanolides. Cells 2022;11:961. [DOI: 10.3390/cells11060961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Binlateh T, Uppatcha N, Thepchai J, Pleungtuk Y, Noisa P, Hutamekalin P, Jitprasertwong P. Cordycepin attenuates migration and invasion of HSC-4 oral squamous carcinoma cells through autophagy-dependent FAK/Akt and MMP2/MMP9 suppression. Journal of Dental Sciences 2022. [DOI: 10.1016/j.jds.2022.03.002] [Reference Citation Analysis]
29 Park KR, Leem HH, Kwon YJ, Kwon IK, Hong JT, Yun HM. Falcarindiol Stimulates Apoptotic and Autophagic Cell Death to Attenuate Cell Proliferation, Cell Division, and Metastasis through the PI3K/AKT/mTOR/p70S6K Pathway in Human Oral Squamous Cell Carcinomas. Am J Chin Med 2022;50:295-311. [PMID: 34931585 DOI: 10.1142/S0192415X22500112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Swarup N, Hong K, Chawla K, Choi S, Shin J, Oh K, Yoon H, Lee J, Cho S, Hong S. Effect of PAIP1 on the metastatic potential and prognostic significance in oral squamous cell carcinoma. Int J Oral Sci 2022;14. [DOI: 10.1038/s41368-022-00162-8] [Reference Citation Analysis]
31 Banik K, Khatoon E, Harsha C, Rana V, Parama D, Thakur KK, Bishayee A, Kunnumakkara AB. Wogonin and its analogs for the prevention and treatment of cancer: A systematic review. Phytotherapy Research. [DOI: 10.1002/ptr.7386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
32 He S, Chakraborty R, Ranganathan S. Proliferation and Apoptosis Pathways and Factors in Oral Squamous Cell Carcinoma. Int J Mol Sci 2022;23:1562. [PMID: 35163485 DOI: 10.3390/ijms23031562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
33 Wu L, Xu S, Cheng X, Zhang L, Wang Y, Wu J, Bao J, Yu H, Lu R. Capsaicin inhibits the stemness of anaplastic thyroid carcinoma cells by triggering autophagy-lysosome mediated OCT4A degradation. Phytother Res 2022. [PMID: 35076979 DOI: 10.1002/ptr.7361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Usman S, Jamal A, Teh MT, Waseem A. Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance. Front Oral Health 2020;1:603160. [PMID: 35047986 DOI: 10.3389/froh.2020.603160] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
35 Luo Y, He Z, Liu W, Zhou F, Liu T, Wang G, Bravo L. DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/3369858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Park KR, Lee H, Kim SH, Yun HM. Paeoniflorigenone regulates apoptosis, autophagy, and necroptosis to induce anti-cancer bioactivities in human head and neck squamous cell carcinomas. J Ethnopharmacol 2022;:115000. [PMID: 35051602 DOI: 10.1016/j.jep.2022.115000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Bostan M, Ion G, Mihaila M, Roman V, Constantin C, Neagu MT. Oxidative Stress Player in Head and Neck Cancer Therapy Response. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_39] [Reference Citation Analysis]
38 Jesse Joel T, John J, Gomez LA, Shepherd R. Novel Developmental Therapeutics Targeting Human Oral Squamous Cell Carcinoma Through Reactive Oxygen Species-Mediated Apoptosis. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_214-1] [Reference Citation Analysis]
39 Jesse Joel T, John J, Gomez LA, Shepherd R. Novel Developmental Therapeutics Targeting Human Oral Squamous Cell Carcinoma Through Reactive Oxygen Species-Mediated Apoptosis. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_214] [Reference Citation Analysis]
40 Jit BP, Pradhan B, Dash R, Bhuyan PP, Behera C, Behera RK, Sharma A, Alcaraz M, Jena M. Phytochemicals: Potential Therapeutic Modulators of Radiation Induced Signaling Pathways. Antioxidants (Basel) 2021;11:49. [PMID: 35052553 DOI: 10.3390/antiox11010049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
41 Rana V, Parama D, Khatoon E, Girisa S, Sethi G, Kunnumakkara AB. Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer. Biomolecules 2021;11:1847. [PMID: 34944491 DOI: 10.3390/biom11121847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Li L, Yin Y, Nan F, Ma Z. Circ_LPAR3 promotes the progression of oral squamous cell carcinoma (OSCC). Biochem Biophys Res Commun 2021;589:215-22. [PMID: 34922206 DOI: 10.1016/j.bbrc.2021.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Wang X, Chen Q. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway. BMC Oral Health 2021;21:598. [PMID: 34814915 DOI: 10.1186/s12903-021-01955-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Janecka-Widła A, Majchrzyk K, Mucha-Małecka A, Słonina D, Biesaga B. Prognostic potential of Akt, pAkt(Ser473) and pAkt(Thr308) immunoreactivity in relation to HPV prevalence in head and neck squamous cell carcinoma patients. Pathol Res Pract 2021;229:153684. [PMID: 34839095 DOI: 10.1016/j.prp.2021.153684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Verma E, Kumar A, Devi Daimary U, Parama D, Girisa S, Sethi G, Kunnumakkara AB. Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review. Journal of Functional Foods 2021;86:104660. [DOI: 10.1016/j.jff.2021.104660] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
46 Huang H, Kim MO, Kim KR. Anticancer effects of 6-shogaol via the AKT signaling pathway in oral squamous cell carcinoma. J Appl Oral Sci 2021;29:e20210209. [PMID: 34644781 DOI: 10.1590/1678-7757-2021-0209] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Alam MM, Marin Fermin J, Spiller PT, Burnett C, Rong X, Moore-Medlin T, Maxwell CO, Khandelwal AR, Nathan CO. Rapalogs induce non-apoptotic, autophagy-dependent cell death in HPV-negative TP53 mutant head and neck squamous cell carcinoma. Mol Carcinog 2021. [PMID: 34598317 DOI: 10.1002/mc.23357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Benvenuto M, Ciuffa S, Focaccetti C, Sbardella D, Fazi S, Scimeca M, Tundo GR, Barillari G, Segni M, Bonanno E, Manzari V, Modesti A, Masuelli L, Coletta M, Bei R. Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells. Sci Rep 2021;11:19051. [PMID: 34561494 DOI: 10.1038/s41598-021-98450-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
49 Chua KLM, Chu PL, Tng DJH, Soo KC, Chua MLK. Repurposing Proton Beam Therapy through Novel Insights into Tumour Radioresistance. Clin Oncol (R Coll Radiol) 2021;33:e469-81. [PMID: 34509347 DOI: 10.1016/j.clon.2021.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Kumar A, Harsha C, Parama D, Girisa S, Daimary UD, Mao X, Kunnumakkara AB. Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases. Phytother Res 2021. [PMID: 34498308 DOI: 10.1002/ptr.7264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
51 Beltran JF, Viafara-garcia S, Labrador AP, Basterrechea J. The Role of Periodontopathogens and Oral Microbiome in the Progression of Oral Cancer. A Review. TODENTJ 2021;15:367-76. [DOI: 10.2174/1874210602115010367] [Reference Citation Analysis]
52 Parama D, Rana V, Girisa S, Verma E, Daimary UD, Thakur KK, Kumar A, Kunnumakkara AB. The promising potential of piperlongumine as an emerging therapeutics for cancer. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00049] [Reference Citation Analysis]
53 Song A, Wang Y, Jiang F, Yan E, Zhou J, Ye J, Zhang H, Ding X, Li G, Wu Y, Zheng Y, Song X. Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling. Mol Cells 2021;44:468-80. [PMID: 34230226 DOI: 10.14348/molcells.2021.2229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
54 Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, Kalia K, Mandoli A. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol 2021;121:105451. [PMID: 34329869 DOI: 10.1016/j.oraloncology.2021.105451] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
55 Oto J, Herranz R, Plana E, Sánchez-González JV, Pérez-Ardavín J, Hervás D, Fernández-Pardo Á, Cana F, Vera-Donoso CD, Martínez-Sarmiento M, Medina P. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. Int J Mol Sci 2021;22:7913. [PMID: 34360679 DOI: 10.3390/ijms22157913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
56 Huang H, Yi JK, Lim SG, Park S, Zhang H, Kim E, Jang S, Lee MH, Liu K, Kim KR, Kim EK, Lee Y, Kim SH, Ryoo ZY, Kim MO. Costunolide Induces Apoptosis via the Reactive Oxygen Species and Protein Kinase B Pathway in Oral Cancer Cells. Int J Mol Sci 2021;22:7509. [PMID: 34299129 DOI: 10.3390/ijms22147509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
57 Girisa S, Saikia Q, Bordoloi D, Banik K, Monisha J, Daimary UD, Verma E, Ahn KS, Kunnumakkara AB. Xanthohumol from Hop: Hope for cancer prevention and treatment. IUBMB Life 2021;73:1016-44. [PMID: 34170599 DOI: 10.1002/iub.2522] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
58 Meng Y, Li X. Expression and Prognosis Analysis of SUMOylation Regulators in Oral Squamous Cell Carcinoma Based on High-Throughput Sequencing. Front Genet 2021;12:671392. [PMID: 34267779 DOI: 10.3389/fgene.2021.671392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
59 Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, Sharifzadeh SO, Soleymani L, Daneshi S, Hushmandi K, Khan H, Kumar AP, Aref AR, Samarghandian S. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother 2021;141:111824. [PMID: 34175815 DOI: 10.1016/j.biopha.2021.111824] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
60 Liu H, Xu X, Wu R, Bi L, Zhang C, Chen H, Yang Y. Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway. Biomed Res Int 2021;2021:6616547. [PMID: 34212035 DOI: 10.1155/2021/6616547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Oura K, Morishita A, Tani J, Masaki T. Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review. Int J Mol Sci 2021;22:5801. [PMID: 34071550 DOI: 10.3390/ijms22115801] [Cited by in Crossref: 40] [Cited by in F6Publishing: 56] [Article Influence: 20.0] [Reference Citation Analysis]
62 Lei CS, Kung HJ, Shih JW. Long Non-Coding RNAs as Functional Codes for Oral Cancer: Translational Potential, Progress and Promises. Int J Mol Sci 2021;22:4903. [PMID: 34063159 DOI: 10.3390/ijms22094903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
63 Nakamura A, Kakihara Y, Funayama A, Haga K, Mikami T, Kobayashi D, Yoshida Y, Izumi K, Kobayashi T, Saeki M. HEATR1, a novel interactor of Pontin/Reptin, stabilizes Pontin/Reptin and promotes cell proliferation of oral squamous cell carcinoma. Biochem Biophys Res Commun 2021;557:294-301. [PMID: 33894417 DOI: 10.1016/j.bbrc.2021.04.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Makvandi P, Josic U, Delfi M, Pinelli F, Jahed V, Kaya E, Ashrafizadeh M, Zarepour A, Rossi F, Zarrabi A, Agarwal T, Zare EN, Ghomi M, Kumar Maiti T, Breschi L, Tay FR. Drug Delivery (Nano)Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management. Adv Sci (Weinh) 2021;8:2004014. [PMID: 33898183 DOI: 10.1002/advs.202004014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 21.5] [Reference Citation Analysis]
65 Girisa S, Kumar A, Rana V, Parama D, Daimary UD, Warnakulasuriya S, Kumar AP, Kunnumakkara AB. From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach. ACS Pharmacol Transl Sci 2021;4:647-65. [PMID: 33860191 DOI: 10.1021/acsptsci.1c00017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
66 Aswathy M, Banik K, Parama D, Sasikumar P, Harsha C, Joseph AG, Sherin DR, Thanathu MK, Kunnumakkara AB, Vasu RK. Exploring the Cytotoxic Effects of the Extracts and Bioactive Triterpenoids from Dillenia indica against Oral Squamous Cell Carcinoma: A Scientific Interpretation and Validation of Indigenous Knowledge. ACS Pharmacol Transl Sci 2021;4:834-47. [PMID: 33860206 DOI: 10.1021/acsptsci.1c00011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
67 Medda A, Duca D, Chiocca S. Human Papillomavirus and Cellular Pathways: Hits and Targets. Pathogens 2021;10:262. [PMID: 33668730 DOI: 10.3390/pathogens10030262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
68 Malik A, Thanekar U, Amarachintha S, Mourya R, Nalluri S, Bondoc A, Shivakumar P. "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Front Oncol 2020;10:627701. [PMID: 33718121 DOI: 10.3389/fonc.2020.627701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
69 Babicheva A, Makino A, Yuan JX. mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target. Int J Mol Sci 2021;22:2144. [PMID: 33670032 DOI: 10.3390/ijms22042144] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
70 Rong JH, Li D, Li YL. Lobaplatin Enhances Radioactive 125I Seed-Induced Apoptosis and Anti-Proliferative Effect in Non-Small Cell Lung Cancer by Suppressing the AKT/mTOR Pathway. Onco Targets Ther 2021;14:289-300. [PMID: 33469307 DOI: 10.2147/OTT.S288012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
71 Daimary UD, Parama D, Rana V, Banik K, Kumar A, Harsha C, Kunnumakkara AB. Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases. Current Research in Pharmacology and Drug Discovery 2021;2:100008. [DOI: 10.1016/j.crphar.2020.100008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
72 Jhou AJ, Chang HC, Hung CC, Lin HC, Lee YC, Liu WT, Han KF, Lai YW, Lin MY, Lee CH. Chlorpromazine, an antipsychotic agent, induces G2/M phase arrest and apoptosis via regulation of the PI3K/AKT/mTOR-mediated autophagy pathways in human oral cancer. Biochem Pharmacol 2021;184:114403. [PMID: 33388284 DOI: 10.1016/j.bcp.2020.114403] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
73 Ahmed SA, Parama D, Daimari E, Girisa S, Banik K, Harsha C, Dutta U, Kunnumakkara AB. Rationalizing the therapeutic potential of apigenin against cancer. Life Sci 2021;267:118814. [PMID: 33333052 DOI: 10.1016/j.lfs.2020.118814] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
74 Alexandra T, Marina IM, Daniela M, Ioana SI, Maria B, Radu R, Maria TA, Tudor S, Maria G. Autophagy-A Hidden but Important Actor on Oral Cancer Scene. Int J Mol Sci 2020;21:E9325. [PMID: 33297472 DOI: 10.3390/ijms21239325] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
75 Tang W, Du M, Zhang S, Jiang H. Therapeutic effect of curcumin on oral diseases: A literature review. Phytotherapy Research 2021;35:2287-95. [DOI: 10.1002/ptr.6943] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
76 Singh AK, Roy NK, Bordoloi D, Padmavathi G, Banik K, Khwairakpam AD, Kunnumakkara AB, Sukumar P. Orai-1 and Orai-2 regulate oral cancer cell migration and colonisation by suppressing Akt/mTOR/NF-κB signalling. Life Sci 2020;261:118372. [PMID: 32882268 DOI: 10.1016/j.lfs.2020.118372] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
77 Parama D, Boruah M, Yachna K, Rana V, Banik K, Harsha C, Thakur KK, Dutta U, Arya A, Mao X, Ahn KS, Kunnumakkara AB. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases. Life Sci 2020;260:118182. [PMID: 32781063 DOI: 10.1016/j.lfs.2020.118182] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 17.7] [Reference Citation Analysis]